HIGHLIGHTS
- who: Manoj Amrutkar and Ivar P. Gladhaug from the Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway have published the research work: Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer, in the Journal: Cancers 2021, 13, 601. of /2021/
- what: Unlike many other solid tumors, pancreatic tumors are extremely chemoresistant and highly metabolically active.
- future: Various attempts to alter or target PSCs and their secretions have largely been unsuccessful underscoring the importance of future investigations into the roles of PSCs in attempts to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.